KNSA logo

Kiniksa Pharmaceuticals (KNSA) Total Expenses

Annual Total Expenses

$468.86 M
+$173.40 M+58.69%

December 31, 2024


Summary


Performance

KNSA Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKNSAexpensesmetrics:

Quarterly Total Expenses

$141.84 M
+$19.96 M+16.38%

December 31, 2024


Summary


Performance

KNSA Quarterly Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKNSAexpensesmetrics:

Total Expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

KNSA Total Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+58.7%0.0%
3 y3 years+140.2%+158.5%
5 y5 years+175.9%+335.3%

KNSA Total Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+140.2%at high+206.1%
5 y5-yearat high+197.9%at high+382.6%
alltimeall timeat high+1853.4%at high+2709.7%

Kiniksa Pharmaceuticals Total Expenses History

DateAnnualQuarterly
Dec 2024
$468.86 M(+58.7%)
$141.84 M(+16.4%)
Sep 2024
-
$121.87 M(+12.1%)
Jun 2024
-
$108.75 M(+12.8%)
Mar 2024
-
$96.40 M(+15.7%)
Dec 2023
$295.45 M(+40.4%)
$83.31 M(+6.8%)
Sep 2023
-
$77.97 M(+4.5%)
Jun 2023
-
$74.63 M(+25.3%)
Mar 2023
-
$59.54 M(+6.6%)
Dec 2022
$210.41 M(+7.8%)
$55.84 M(+5.9%)
Sep 2022
-
$52.72 M(+13.8%)
Jun 2022
-
$46.34 M(-16.5%)
Mar 2022
-
$55.51 M(+1.2%)
Dec 2021
$195.18 M(+24.0%)
$54.88 M(+28.3%)
Sep 2021
-
$42.76 M(-11.4%)
Jun 2021
-
$48.26 M(-2.1%)
Mar 2021
-
$49.28 M(-6.8%)
DateAnnualQuarterly
Dec 2020
$157.36 M(-7.4%)
$52.90 M(+22.4%)
Sep 2020
-
$43.22 M(+35.6%)
Jun 2020
-
$31.86 M(+8.4%)
Mar 2020
-
$29.39 M(-9.8%)
Dec 2019
$169.96 M(+57.1%)
$32.58 M(+7.0%)
Sep 2019
-
$30.45 M(-22.5%)
Jun 2019
-
$39.29 M(-41.9%)
Mar 2019
-
$67.65 M(+53.3%)
Dec 2018
$108.16 M(+65.4%)
$44.13 M(+68.7%)
Sep 2018
-
$26.16 M(+21.5%)
Jun 2018
-
$21.53 M(+31.7%)
Mar 2018
-
$16.34 M(-50.0%)
Dec 2017
$65.40 M(+172.5%)
$32.71 M(+101.3%)
Sep 2017
-
$16.25 M(+42.6%)
Jun 2017
-
$11.39 M(+125.7%)
Mar 2017
-
$5.05 M
Dec 2016
$24.00 M
-

FAQ

  • What is Kiniksa Pharmaceuticals annual total expenses?
  • What is the all time high annual total expenses for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals annual total expenses year-on-year change?
  • What is Kiniksa Pharmaceuticals quarterly total expenses?
  • What is the all time high quarterly total expenses for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals quarterly total expenses year-on-year change?

What is Kiniksa Pharmaceuticals annual total expenses?

The current annual total expenses of KNSA is $468.86 M

What is the all time high annual total expenses for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high annual total expenses is $468.86 M

What is Kiniksa Pharmaceuticals annual total expenses year-on-year change?

Over the past year, KNSA annual total expenses has changed by +$173.40 M (+58.69%)

What is Kiniksa Pharmaceuticals quarterly total expenses?

The current quarterly total expenses of KNSA is $141.84 M

What is the all time high quarterly total expenses for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high quarterly total expenses is $141.84 M

What is Kiniksa Pharmaceuticals quarterly total expenses year-on-year change?

Over the past year, KNSA quarterly total expenses has changed by $0.00 (0.00%)